Central pontine myelinolysis risk factors: Difference between revisions
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{MMJ}} | {{CMG}}; {{AE}} {{MMJ}} | ||
==Overview== | ==Overview== | ||
The most potent risk factor in the development of central pontine myelinolysis is [[hyponatremia]]. Other risk factors include: Liver dysfunction and [[liver diseases]], [[hypocholesterolemia]], [[alcoholism]], [[malnutrition]], systemic medical disease and [[hemodialysis]]. | |||
==Risk Factors== | ==Risk Factors== | ||
| Line 15: | Line 16: | ||
**Systemic medical disease | **Systemic medical disease | ||
**[[Hemodialysis]] | **[[Hemodialysis]] | ||
==References== | ==References== | ||
Latest revision as of 03:56, 15 August 2019
|
Central pontine myelinolysis Microchapters |
|
Differentiating Central pontine myelinolysis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Central pontine myelinolysis risk factors On the Web |
|
American Roentgen Ray Society Images of Central pontine myelinolysis risk factors |
|
Risk calculators and risk factors for Central pontine myelinolysis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
The most potent risk factor in the development of central pontine myelinolysis is hyponatremia. Other risk factors include: Liver dysfunction and liver diseases, hypocholesterolemia, alcoholism, malnutrition, systemic medical disease and hemodialysis.
Risk Factors
Common Risk Factors
- The most potent risk factor in the development of central pontine myelinolysis is hyponatremia.
- Other risk factors include:[1][2][3][4]
- Liver dysfunction and liver diseases
- Hypocholesterolemia
- Alcoholism
- Malnutrition
- Systemic medical disease
- Hemodialysis
References
- ↑ Lee EM, Kang JK, Yun SC, Kim KH, Kim SJ, Hwang KS; et al. (2009). "Risk factors for central pontine and extrapontine myelinolysis following orthotopic liver transplantation". Eur Neurol. 62 (6): 362–8. doi:10.1159/000242426. PMID 19797900.
- ↑ Jacob S, Gupta H, Nikolic D, Gundogdu B, Ong S (2014). "Central pontine and extrapontine myelinolysis: the great masquerader-an autopsy case report". Case Rep Neurol Med. 2014: 745347. doi:10.1155/2014/745347. PMC 3970353. PMID 24716023.
- ↑ Martin RJ (2004). "Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes". J Neurol Neurosurg Psychiatry. 75 Suppl 3: iii22–8. doi:10.1136/jnnp.2004.045906. PMC 1765665. PMID 15316041.
- ↑ Oo TN, Smith CL, Swan SK (2003). "Does uremia protect against the demyelination associated with correction of hyponatremia during hemodialysis? A case report and literature review". Semin Dial. 16 (1): 68–71. PMID 12535304.